Triazine antiviral compounds
CA 2318362 A1 · Owner: Fleming, Elizabeth S. · Inventors: Fleming, Elizabeth S.; Xiang, Yi Bin; Arenas, Jaime E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides pharmaceutical formulations comprising 1,3,5triazine derivatives. The compounds and formulations of the present invention exhibit a range of activities, including antiviral and antibiotic activities and the formulations may be used, alone or in combination as a method of , treating a patient in need of antiviral and/or antibiotic therapy. The triazine derivatives of the present invention bind to and inhibit functional nucleic acids, and hence, have broad applicability in the treatment of conditions associated with DNA and RNA viruses.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 13, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 13, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 13, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.